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Amoebiasis is an infection caused by water borne protozoan parasite Entamoeba histolytica. In Uganda where sanitation 
infrastructure and health education was not adequate, amoebiasis was thought to be still an important health problem. However 
there was little or no data on prevalence of this very important protozoan infection. In addition, microscopy remained the main 
method for the diagnosis of amoebiasis but could not differentiate between Entamoeba dispar/moshkovskii and Entamoeba histolytica 
infections. This made determination of true prevalence of Entamoeba histolytica infections difficult. It was against this background 
that this study was designed to carry out species specific diagnosis of Entamoeba histolytica and Entamoeba dispar/moshkovskii in 
Uganda where these species had been reported to be endemic. This study used microscopy and polymerase chain reaction 
amplification of Serine-rich Entamoeba histolytica (SREHP) gene. It was shown that 36.7% (n=22) of the samples initially diagnosed as 
positive by microscopy were positive by PCR. The true prevalence of E. histolytica and E.dispar/ moshkovskii was found to be 7.31% 
and 12.6% respectively. It was concluded that Entamoeba infection in Soroti, Eastern Uganda is more frequently due to E. dispar 
/moshkovskii (13.3%) the non-pathogenic forms than to E. histolytica, the pathogen (7.31%). 
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INTRODUCTION 
New efforts are being made to improve the 
understanding of the epidemiology of the helminths 
and intensifying the control efforts against these 
parasites. In contrast, relatively few studies are being 
carried out in this direction for the intestinal protozoa 
(1). Microscopy remains the main method used for 
the diagnosis of amoebiasis in most African countries, 
however, it cannot differentiate between Entamoeba 
dispar and Entamoeba histolytica.In Bangladesh, only 
40% of patients diagnosed by microscopy were  
 
proven to have E. histolytica infection when specific 
methods were used. In addition, the accuracy of this 
method in detecting Entamoeba histolytica depends 
heavily on skills of the technician and has been shown 
to be less sensitive and less specific as compared to 
other methods such as immuno-florescence (IFA), 
antigen detection and PCR(2).  
Molecular methods, such as PCR, have aided in 
alleviating some of the sensitivity and specificity 
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deficiencies associated with traditional methods for 
the detection of protozoan pathogens. A number of 
PCR-based assays like gene amplification with 
specific primers, multiplex PCR, restriction fragment 
length polymorphism and real-time PCR have been 
developed for the identification of E.histolytica 
infections (3). In Mexico, E.histolytica prevalence of 
25.3% in the HIV/AIDS group and 18.5% in the HIV-
negative group was described using PCR (4). Dhawan 
(5) estimated the prevalence rate of amoebiasis in the 
United States to be approximately 4% with E dispar 
infection, which is always asymptomatic, being 10 
times more common than E histolytica infection. 
Despite the development of sensitive antigen-based 
and molecular techniques, there was no information 
on the true prevalence of E. histolytica in Uganda (6). 
Very few studies in Africa have used molecular 
methods to determine the prevalence of E.histolytica. 
As a consequence, large gaps remain on prevalence 
rates of Entamoeba histolytica. Estimates of prevalence 
rates of E. histolytica is an important decision making 
tool in allocation of limited public health resources, its 
treatment, prevention and control. Also feasibility of 
developing an amoebiasis vaccine depends on the 
estimation of the disease burden among the 
populations in the high risk areas (7, 8).  It was 
against this background that this study was designed 
to carry out  species specific diagnosis of Entamoeba 
histolytica, Entamoeba dispar and Entamoeba moshkovskii 
in Uganda where Entamoeba histolytica and Entamoeba 
dispar had been reported to be endemic (9). 
MATERIALS AND METHODS  
Isolation of amoebic DNA from isolates of 
Entamoeba histolytica  
Sixty faecal samples initially diagnosed as positive by 
microscopy were stored frozen. For DNA isolation, 
200 µl of faecal suspension (0.5 g/ml PBS) was added 
to 200 µl of 4% polyvinylpolypyrolidone (PVPP) 
(Sigma) suspension and heated for 10 min at 100 °C 
(10). DNA isolation was then done according to the 
method of Samie et al.(11). The genomic DNA was 
purified from stool samples using the QIAamp DNA 
Stool Mini Kit from Qiagen (Qiagen GmbH, Hilden, 
Germany) with some modifications. Briefly, 250 µl of 
liquid stool or diluted stool material was added to 50 
µl of potassium hydroxide and 15 µl of 1 mol/L 
dithiothreitol and mixed thoroughly. After a 30-
minute incubation period at 65°C, 8.2 µl of 25% HCl 
and 80 µl of 2 mol/L Tris-HCl (pH 8.3) were added to 
the mixture. After a brief vortexing, the protocol was 
continued with the Qiagen mini kit following the 
manufacturer’s instructions.  
PCR amplification of Ser-rich Entamoeba histolytica 
Protein gene 
The amoebic Ser-rich protein gene repeats were 
amplified using PCR and primers specific for E. 
histolytica. An E. histolytica Ser-rich protein-specific 
sense primer was 
GCTAGTCCTGAAAAGCTTGAAGAAGCTG 
(Primer1), while an E. histolytica Ser-rich protein-
specific antisense primer was 
GGACTTGATGCAGCATCAAGGT (12). The 
procedure was as follows: all solutions were gently 
vortexed and briefly centrifuged after thawing. Using 
a thin-walled PCR tube on ice, the reaction mixtures 
were added as follows: 10 X PCR buffer 2.5 µl, 10 mM 
dNTPs 5.0 µl, 25 mM MgCl2 5.0 µl, 50 pmoLPrimer1 
1.0 µl, 50 pmoL Primer2 1.0 µl, Taq polymerase 0.3 µl, 
distilled water 1.5 µl, DNA sample 3.0 µl. Samples 
were again gently vortexed and briefly centrifuged to 
collect all drops from walls of tubes. Samples were 
then placed in a thermocycler and set as follows: 
denaturation at 94ºC for 3 minutes, annealing at 55ºC 
for 1 minute, extension at 72ºC for 2 minutes and 
whole process repeated for 35 cycles. The PCR 
products were identified on 12% polyacrylamide gel 
electrophoresis at 80 volts for four hours. Standard 
strain E. histolytica HM-1: IMSS to be used as positive 
control, could not be obtained. However, a negative 
control was used. The negative control was prepared 
as follows: 10 X PCR buffer 2.5 µl, 10 mM dNTPs 5.0 
µl, 25 mM MgCl2 5.0 µl, 50 pmoLPrimer1 1.0 µl, 50 
pmoL Primer2 1.0 µl, Taq polymerase 0.3 µl, distilled 
water 4.5 µl.  
RESULTS   
It was shown that only 22 of the 60 samples (33.3%) 
initially diagnosed as positive by microscopy were 
positive by PCR (Figure 1).Two strains of E. histolytica 
were common, being detected in five separate 
patients. The patients whose samples were identified 
as: 4, 9, 11, 12, 16 seemed to be infected by a similar 
strain. While patients whose sample identity were: 2, 
7, 18, 20 and 22 also seemed to be infected with 
another strain. However, each of the six strains (8, 10, 
13, 14, 15, 21) were detected in only one patient.
 
              M N 1 2 3 4 
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Figure 1: Gel photographs of SREHP PCR products amplified from DNA of 
Soroti. 1-22 are the positive samples; M is a 100 bp marker while N is negative control.
DISCUSSION 
Entamoeba histolytica infections are common in Sub
Saharan Africa but the true prevalence 
and disease caused by Entamoeba histolytica
unknown for Uganda and most of Sub
Africa. This was attributed to the fact that until 
relatively recently the laboratory differentiation of 
histolytica from the morphologically identical non
pathogenic amoebic species E. dispar/moshkovskii
not possible. However, differential identification of 
histolytica and E. dispar is essential for both
appropriate patient treatment and epidemiological
purposes. Despite the development of sensitive 
antigen-based and molecular techniques; there was
no other information on the diversity of 
strains in Uganda.  As a consequence,
remained in our knowledge of species prevalence 
rates. To address this, species specific diagnosis of 
histolytica was performed among isolates from Soroti. 
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In this study, the amoebic Ser-rich protein
were amplified using direct PCR using primers that 
are specific for E. histolytica. The results showed that 
only 33.3% of samples initially diagnosed as positive 
by microscopy were positive by PCR (Figure 1). This 
gave overall true prevalence 7.31% of 
These results are consistent with earlier observations 
that Entamoeba infection in Africa is more frequently 
due to E. dispar than to E. histolytica.
observations have been made in Brazil, Nicaragua, 
and Italy (13). Australia exhibits the highest frequency 
of E. dispar (73.3%) and E. 
infection, which were detected in a population 
referred to as a clinical laboratory service where 2.9% 
of samples were microscopically positive for 
Entamoeba cysts (13). In contrast, in countries along 
the Pacific coast, the frequency and prevalence data 
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for E. histolytica infection seem to be higher or similar 
to those obtained for E. dispar. The data available for 
the frequency of E. histolytica infection in the Middle 
East show that cases in the Gaza Strip in Palestine 
detected in hospitalized patients exhibited a 69.5% 
frequency, as compared to Saudi Arabia with a 
frequency of 2.7% in a similar population (14, 15).  
The PCR resulted into mostly single but also multiple 
bands. This PCR product length polymorphism was 
thought to result from size variations within the 
SREHP gene. There is evidence to suggest that the E. 
histolytica SREHP genome is tetrapoid (16, 17). This 
could have accounted for the multiple bands that 
were observed and may reflect polymorphism among 
homologous loci on allelic chromosomes. Another 
factor that could account for multiple bands was the 
existence of the repeat loci at multiple locations in the 
E. histolytica genome each with a characteristic PCR 
product. To further support this argument, it has 
previously been shown that SREHP appears to be a 
single copy gene only when analyzed using Southern 
blots. However, when the repeat region is amplified 
from a clonal line of an E. histolytica isolate, often two 
or three bands are observed, not always of equal 
intensity but usually quite close in size (18). This 
suggested that multiple alleles can be present and that 
the ploidy is likely to be four. The major way in which 
the alleles differ was said to be in the number of 8 and 
12 amino acid repeats that are present, but there are 
sequence differences between the DNA repeats also. 
It could also be argued that since there are different 
strains of Entamoeba histolytica in the environment and 
that humans are continuously exposed to them in a 
similar manner, it is possible for a single host to be 
infected by more than one strain at the same time. 
Multiple bands could then result from infection of a 
single patient with several different strains of 
Entamoeba histolytica. This can be from the same point 
source or different sources infected at the same time 
or different times. Besides parasite mutations during 
infection can produce modified strains capable of 
being distinguished from the original strain and thus 
resulting in multiple bands in the same patient.  
In conclusion, Entamoeba infection in Soroti, Eastern 
Uganda is more frequently due to E. dispar 
/moshkovskii (13.3%) the non-pathogenic forms than 
to E. histolytica, the pathogen (7.31%). 
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